UnknownNot Applicable

Occluder Size Determination in Transcatheter ASD II Closure Based on 3D TEE Assessment

Poland50 participantsStarted 2015-01

Plain-language summary

The aim of this study is to determine whether three-dimensional tranesophageal echocardiography (3D TEE) assessment of ostium secundum atrial septal defect (ASD II) may be as efficient as two-dimensional (2D) TEE assessment complemented by the balloon-sizing during transcatheter closure of the defect.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASD II suitable for percutaneous treatment * free and informed consent to analyze the medical data of the person concerned * age: patients over 16 Exclusion Criteria: * ASD II not suitable for percutaneous treatment * any valvular heart disease requiring cardiac surgery * no free and informed consent to analyze the medical data of the person concerned * age: under 16

What they're measuring

Correlation between the proposed and actual device size.

Timeframe: 18 months

Trial details

NCT IDNCT02601768

SponsorNational Institute of Cardiology, Warsaw, Poland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-06

Contact for this trial

Jan Henzel, MD

600699211 jhenzel@ikard.pl

View on ClinicalTrials.gov More Ostium Secundum Atrial Septal Defect trials